Detalhe da pesquisa
1.
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.
J Immunol
; 211(2): 295-305, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37256255
2.
Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.
Proc Natl Acad Sci U S A
; 118(24)2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34099563
3.
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
Nat Chem Biol
; 17(9): 937-946, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33767387
4.
Targeted glycan degradation potentiates the anticancer immune response in vivo.
Nat Chem Biol
; 16(12): 1376-1384, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32807964
5.
Design of a mucin-selective protease for targeted degradation of cancer-associated mucins.
Nat Biotechnol
; 42(4): 597-607, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37537499
6.
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression.
Cell Chem Biol
; 29(3): 451-462.e8, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34774126
7.
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
Neuro Oncol
; 23(12): 2042-2053, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34050676
8.
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
Sci Rep
; 10(1): 15171, 2020 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32938950